ArticleJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology2026
Pg-Induced ATR Activation Promotes ESCC Progression via M2 TAM Polarization.
Article in Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundEmerging evidence suggests that oral pathogens may contribute to the development of systemic malignancies. Porphyromonas gingivalis (Pg), a major periodontal pathogen, has been implicated in several cancers including esophageal squamous cell carcinoma (ESCC). However, the molecular mechanisms underlying this association remain unclear.
objectiveThis study aimed to investigate the impact of Porphyromonas gingivalis (Pg) on the growth of esophageal squamous cell carcinoma (ESCC) and its potential mechanisms.
methodsTHP-1 cells were differentiated into M0 macrophages with PMA and divided into control group, Pg group, and Pg + siATR group. THP-1 cells were divided into three groups: control group, Pg group, and Pg + siATR group. The control and Pg groups were transfected with siNC, while the Pg + siATR group was transfected with siATR. After transfection, the Pg group and Pg + siATR group were incubated with 200 MOI pg. The control group was cultured normally. Cells and supernatants were collected, and macrophage polarization status was detected with qRT-PCR, Western blot, and flow cytometry. Macrophages treated differently were co-cultured with human esophageal squamous cell carcinoma cell line KYSE150. The proliferation, invasion, and apoptosis of KYSE150 were examined. KYSE150+shATR and KYSE150+shNC cell lines were constructed with a lentivirus system. Thirty male BALB/c mice aged 6-8 weeks were randomly divided into control group, pg group, and pg+shATR group, with 10 mice in each group. For the Pg and Pg+shATR groups, 200 μL Pg (1 × 10
resultsIn this study, we found that Pg could promote the polarization of M0 macrophages into M2 macrophages, while also promoting the malignant progression of KYSE150 cells. The expression levels of ATR, phosphorylated ATR (p-ATR), and M2 macrophage markers (CD206, Arg1, and VEGF) decreased when ATR was inhibited. In BALB/c mice, Pg-induced ATR activation promoted the growth of subcutaneously implanted tumors by recruiting M2-type TAMs. Experimental data also indicated an association between M2 polarization, decreased p-chik, and ATR.
conclusionThis study reveals that Pg can activate the ataxia-telangiectasia and Rad3-related protein (ATR) signaling pathway, inducing the polarization of M2 tumor-associated macrophages (TAM), thereby promoting the growth of ESCC. This provides a new theoretical basis for the prevention and treatment of ESCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.